HIV-1 tat protein induces the production of interleukin-8 by human brain-derived endothelial cells

Journal of Neuroimmunology

Volumn 94, Issue 1-2, 1999, Pages 28-39

  Hofman, Florence M ^a   Chen, Peijia ^a   Incardona, Francesca ^a   Zidovetzki, Raphael ^b   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS HIV; Brain; Endothelial cells; IL 8; Tat

Indexed keywords

INTERLEUKIN 8; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREGULATION; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN SECRETION; T LYMPHOCYTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAIN; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; ENDOTHELIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV-1; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MALE; NEUTROPHILS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033081556     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00198-2     Document Type: Article

References (71)

1. Ando K., Moriyama T., Guidotti L.G., Wirth S., Schreiber R.D., Schlicht H.J., Huang S., Chisari F.V. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178:1993;1541-1554.
2. 1. J. Clin. Endo. Metabol. 81(8):1996;3004-3009.
3. Baggiolini M., Walz A., Kunkel S.H. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84:1989;1045-1049.
4. Breen E.C., Razai A.R., Nakajima K., Beall G.N., Mitsuyasu R.T., Hirano T., Kishimoto T., Marinez-Maza O. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol. 144:1990;480-484.
5. Capobianchi M.R., Barresi C., Borghi P., Gessani S., Fantuzzi L., Ameglio F., Belardelli F., Papdia S., Dianizani F. Human immunodeficiency virus type1 gp 120 stimulates cytomegalovirus replication in monocytes: Possible role of endogenous interleukin-8. J. Virol. 71(2):1997;1591-1597.
6. 2 and soluble p55 TNF R modulate VCAM-1 expression in glioma cells and brain derived endothelial cells. Neuroimmunology. 73:1997;155-161.
7. 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine. 8(1):1996;58-65.
8. + T cells. Science. 270(5243):1995;1811-1815.
9. 3 by glioblastoma cells, astrocytes and microglia. J. Immunol. 148(15):1992;1404-1410.
10. Denis M., Ghardirian E. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res. Hum. Retroviruses. 10:1994;1619-1627.
11. 1 enhances polymorphonuclear leukocyte accumulation in dermal inflammation and transendothelial migration by a priming action. Immunology. 78(2):1993;197-204.
12. Elner S.G., Elner V.M., Bian Z.M., Lukacs N.W., Kurtz R.M., Stuefer R.M., Kunkel S.L. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T lymphocyte products. IOVS. 38(2):1997;446-455.
13. Ensoli B., Barillari G., Salahuddin C.Z., Gallo R.C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345:1990;84-86.
14. Ensoli B., Buonagoro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J. Virology. 67:1993;277-287.
15. Esser R., Glienke W., von Briesen M., Rübsamen-Waigmann H., Anderson R. Differential regulation of proinflammatory and hematopoeitc cytokines in human macrophages after infection with human immunodeficiency virus. Blood. 88(9):1996;3474-3481.
16. Esser R., von Briesen H., Brugger M., Ceska M., Glienke W., Muller S., Rehm A., Rübsamen-Waigmann H. Secretory repertoire of HIV-infected human monocytes/macrophages. Pathology. 59:1991;219-222.
17. 2 decrease migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J. Immunol. 155:1995;325-332.
18. Fauci A.S. The human immunodeficiency virus type 1: infectivity and mechanism of pathogenesis. Science. 239:1988;617-622.
19. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 tat protein: an immune response to human herpesvirus-8 infection? Blood. 91:1998;956-967.
20. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 55:1988;1189-1193.
21. Gabrielian K., Osusky R., Sippy B.D., Ryan S.J., Hinton D.R. Effect of TGFB on interferon-α-induced HLA-DR expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 35:1994;4253-4259.
22. Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23:1989;109-116.
23. Goletti D., Kinter A.L., Hardy E.C., Poli G., Fauci A.S. Modulation of endogenous IL-1β and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J. Immunology. 156(9):1996;3501-3508.
24. He J., Chen Y., Farzan M., Choe M., Ohagen A., Gartnor S., Busciglio J., Yang X., Hofmann W., Newman W., MacKay C.R., Sodroski J., Gabuzuda D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature. 385:1997;845-849.
25. Hofman F.M., Wright A.D., Dohadwala M.M., Wong-Staal F., Walker S.W. Exogenous tat protein activates human endothelial cells. Blood. 82:1993;2774-2780.
26. Hofman F.M., Dohadwala M.M., Wright A.D., Hinton D.R., Walker S.M. Exogenous tat protein activates central nervous system-derived endothelial cells. J. Neuroimmunol. 54:1994;19-28.
27. Jassoy C., Johnson R., Navia B., Worth J., Walker B. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:1992;3113-3119.
28. Jinquan T., Deleuran B., Gesser B., Maare H., Deleuran M., Larsen C.G., Thestrup-Pederson K. Regulation of human T lymphocyte chemotaxis in vitro by T-cell derived cytokines IL-2, IFN-γ, IL-4, IL-10, IL-13. J. Immunol. 154:1995;3742.
29. + T lymphocyte migration. J. Immunol. 151(9):1993;4545-4551.
30. Kaleria R.N., Gravina S.A., Schmidley J.W., Perry G., Harik S.I. The glucose transporter of the human brain and blood-brain barrier. Ann. Neurol. 24:1988;757-764.
31. Karakurum M., Shreeniwas R., Chen J., Pinsky D., Yan S.D., Anderson M., Sunouchi K., Major J., Hamilton T., Kuwabara K., Rot A., Nowyrod R., Stern D. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Invest. 93:1994;1564-1570.
32. Kobayshi S., Yamamoto Y., Kobayashi N., Yamamoto N. Serum level of TWFα in HIV-infected individuals. AIDS. 4:1990;169.
33. Kolson D.L., Buchhalter J., Collman R., Hellmig B., Farrell C.F., Debouck C., Gonzalez-Scarano F. HIV-1 tat alters normal organizations of neurons and astrocytes in primary rodent brain cell cultures: RGD sequence dependence. AIDS Research Human Retroviruses. 9(7):1993;677-685.
34. 1 in rat lung alveolar epithelial cells. J. Cell Physiol. 169(1):1996;186-199.
35. Kuppner M.C., McKillop-Smith S., Forrester J.V. TGFβ and IL-1β act in synergy to enhance IL-6 and IL-8 mRNA levels and IL-6 production by human retinal pigment epithelial cells. Immunology. 84(2):1995;265-271.
36. Kure K., Lyman W.D., Weidenheim K.M., Dickson D.W. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double-labeling immunohistochemical method. Am. J. Pathol. 136:1990;1085-1092.
37. La Frenie R.M., Wahl L.M., Epstein J.S., Yamada K.M., Dhawan S. Activation of monocytes by HIV-tat treatment is mediated by cytokine expression. J. Immunol. 159:1997;4077-4083.
38. Laterra, J., Goldstein, G.W., 1993. Brain microvessels and macrovascular cells in vitro. In Pardridge, W.M. (Ed.), The Blood-Brain Barrier: Cellular and Molecular Biology, Raven Press, New York, 1-24.
39. Laverda A., Gallo P., DeRossi A., Sivieri S., Cogo P., Pagliaro A., Chieco-Bianchi L., Tavolato B. Cerebrospinal fluid analysis in HIV-1 infected children: immunological and virological findings before and after AZT therapy. Acta Pediatr. 83:1994;1038-1042.
40. 2 suppressing IFN-γ induction of class II MHC gene expression by inhibiting class II transactivation messenger RNA expression. J. Immunol. 158:1997;2065-2075.
41. Lepe-Zuniga J.L., Mansell P.W.A., Hersh E.M. Idiopathic production of interleukin-1 in acquired immunodeficiency syndrome. J. Clin. Microbiol. 25:1987;1695.
42. Mankowski J.L., Spelman J.P., Ressetar H.G., Strandberg J.D., Laterra J., Carter D.L., Clements J.E., Zink M.C. Neurovirulent simian immunodeficiency virus replicates productively in endothelial cells of the central nervous system in vivo and in vitro. J. Virol. 68:1994;8202-8208.
43. Matsumoto T., Mike T., Nelson R.P., Trudeau W.L., Lockey R.F., Yodoi J. Elevated serum levels of IL-8 in patients with HIV infection. Clin. Exp. Immunol. 93:1993;149-151.
44. McCartney-Francis N.L., Wahl S.M. Transforming growth factor β: A matter of life and death. J. Leukocyte Biol. 55:1994;401-409.
45. 1 and rat heart endothelial cell anchorage-dependent and independent growth. Exp. Cell Res. 186:1990;122-129.
46. Moses A.V., Bloom F.E., Pauza C.D., Nelson J.A. Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc. Natl. Acad. Sci. USA. 90:1993;10474-10478.
47. Neuwelt E.A., Pagel M.A., Dix R.D. Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier. J. Neurosurg. 74:1991;475-479.
48. Oppenheim J.J., Zachariae C.O.C., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene intercrine cytokine family. Ann. Rev. Immunol. 9:1991;617-648.
49. Penttinen R.P., Kobayashi S., Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. PNAS. 85(4):1988;1105-1108.
50. Petito C.K., Cash K.S. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32:1992;658-666.
51. Pitrak D.L., Tsai H.C., Mullane K.M., Sutton S.H., Stevens P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J. Clin. Invest. 98(12):1996;2714-2719.
52. Plata-Salaman C., Borkoski J. Interleukin-8 modulates feeding by direct action in the central nervous system. Am. J. Physiol. 265:1993;R877-882.
53. Pober J.S., Cotran R.S. The role of endothelial cells in inflammation. Transpl. 50(4):1990;537-544.
54. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann. Neurol. 34:1993;339-350.
55. Sabatier J.M., Vives E., Mabrouk K., Benjouad A., Rochat H., Duval A., Hue B., Bahraoui E. Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virology. 65:1991;961-967.
56. Sippy B.D., Hofman F.M., Wallach D., Hinton D.R. Increased expression of TNF-a receptors in the brains of patients with acquired immune deficiency syndrome. J. Acquired Immune Deficiency Syndrome Hum. Retrovirology. 10:1995;511-524.
57. 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J. Immunol. 157:1996;360-368.
58. Smith T.W., DeGuolami U., Henin D., Bolgert F., Hauw J.J. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J. Neuropathol. Exp. Neurol. 49:1990;357-370.
59. Sopper S., Demuth M., Stahl-Hennig C., Hunsmann G., Plesker R., Coulibaly C., Czub S., Ceska M., Koutsilieri E., Reiderer P., Brinkmann R., Katz M., Ter Meulen V. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology. 220:1996;320-329.
60. Tsai W., Hirose K., Nara P., Kuang Y., Conley S., Li B., Kung H., Matsushima K. Decrease in cytokine production by HIV-infected macrophages in response to LPS-mediated activation. Lymphokine Cytokine Res. 10:1991;421-429.
61. Tyor W.R., Glass J.D., Griffin J.W., Becker S., McArthur J.C., Bezman L., Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
62. Viscidi R.P., Mayur K., Lederman H.M., Frankel A.D. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science. 246:1989;1606-1608.
63. von Herrath M., Oldstone M.B.A., Fox M.S. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV infected rhesus macaques. J. Immunol. 154:1995;5582-5589.
64. Wahl S.M., Hunbt D.A., Wakefield L.M., McCartney-Francis N., Wahl L.M., Roberts A.B., Sporn M.B. Transforming growth factor type beta induces monocyte chemotaxis and growth production. Proc. Natl. Acad. Sci. USA. 84(16):1987;5788-5792.
65. Wahl S.M., Allen J.B., Francis N.M. Macrophage and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J. Exp. Med. 173:1991;981-991.
66. 1 T-cell apoptosis, and the immune privilege of the brain. Brain Res. [Review]. 21(2):1995;128-151.
67. Wesselingh S., Glass J., McArthur J., Griffin J., Griffin D. Cytokine dysregulation in HIV-associated neurological disease. Adv. Neuroimmunol. 4:1994;199-206.
68. Wright S., Jewett A., Mitsuyasu R., Bonavida B. Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J. Immunol. 141:1988;99-104.
69. Yasumoto K., Okamoto N., Mukaida S., Murakami M.M., Matsushima K. Tumor necrosis factor α and interferon-γ synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-KB-like binding sites of the interleukin-8 gene. J. Biol. Chem. 26731:1992;22506-22511.
70. Zauli G., Gibellini D., Milan D., Mazzoni M., Borgatti P., La Placa M., Capitani S. Human immunodeficiency virus type-1 tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:1993;4481-4485.
71. Zauli G., Davis B.R., Carla M., Visani G., Gurlini G., La Placa M. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood. 80(12):1992;3036-3043.